FAQs
Frequently Asked Questions
Answers to common questions from procurement teams, hospitals, CROs, and institutional buyers about sourcing medicines from India and regulated global markets.
Who do you typically work with?
We work with pharmaceutical companies, CROs, hospitals, distributors, government institutions, NGOs, and research organizations worldwide.
Which countries do you export medicines to from India?
We support pharmaceutical exports from India to markets across Latin America, Africa, the Gulf, CIS, and Asia-Pacific, subject to the import regulations and licensing requirements of each destination country.
Can you support bulk procurement for hospitals, distributors, NGOs, and government tenders?
Yes. We support institutional procurement requirements, including bulk orders, tender participation, and long-term supply arrangements across multiple therapeutic categories.
Can you source medicines that are unavailable or discontinued in our country?
Depending on regulatory approvals and market availability, we assist organizations in sourcing hard-to-find, shortage, and specialty medicines from India and other regulated markets.
How do you ensure that exported medicines comply with the importing country's regulations?
Our team reviews country-specific documentation requirements, product registrations, import permits, and shipping conditions before dispatch to support compliant procurement.
What is a Named Patient Program, and who can request medicines under it?
Named Patient Programs enable access to medicines that are not yet approved or commercially available in a country. Requests are generally initiated by licensed physicians, hospitals, or authorized institutions in accordance with local regulatory requirements.
Can you source oncology and rare disease medicines under Named Patient Programs?
Yes. We support sourcing for a range of specialty therapies, including oncology, hematology, and rare disease treatments, depending on product availability and import regulations.
Do you support documentation for Named Patient Program imports?
We assist procurement teams with documentation and coordination required for NPP supply, subject to the regulations of the destination country.
Do you export temperature-sensitive medicines from India?
Yes. We arrange GDP-compliant cold-chain logistics with validated packaging and temperature monitoring for biologics, oncology products, and specialty medicines.
Can you provide comparator medicines from specific regulatory markets such as the US, Europe, or the UK?
Yes. We source comparator products from FDA-, EMA-, and MHRA-regulated markets based on study protocols and regulatory requirements.
Do you support batch-specific procurement for BA/BE studies?
Yes. We can assist with batch-specific sourcing requirements for bioequivalence studies, clinical trials, and research programs, subject to availability.
How do you verify the authenticity of Reference Listed Drugs (RLDs) and comparator medicines?
Comparator products are sourced through authorized supply channels and are supported by batch traceability, product documentation, and chain-of-custody records.
What documents are typically provided with comparator drug shipments?
Depending on the project, documentation may include invoices, Certificates of Analysis (CoA), batch details, labels, packing lists, and shipping records.
Can you support urgent procurement requirements?
Our team evaluates urgent requests on a case-by-case basis and works with global supply partners to minimize procurement timelines whenever possible.
How do you maintain confidentiality for procurement and clinical research projects?
All inquiries and sourcing requirements are handled confidentially and shared only with the teams involved in procurement, compliance, and logistics.
